UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010077
Receipt number R000011805
Scientific Title The effect of histamine on acethylcholine-mediated sweating
Date of disclosure of the study information 2013/02/19
Last modified on 2018/12/31 09:28:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of histamine on acethylcholine-mediated sweating

Acronym

The effect of histamine on sweating

Scientific Title

The effect of histamine on acethylcholine-mediated sweating

Scientific Title:Acronym

The effect of histamine on sweating

Region

Japan


Condition

Condition

Healthy volunteers who were enrolled to this study after they signed an informed consent form and provided written and oral information to the study physicians.

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluating the effect of histamine on sweating

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) axon-reflex mediated sweating volume
2) latency time

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

with or without histamine

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Subjects with signed an informed consent form and provided written and oral information to the study physicians.

Key exclusion criteria

- The part-time-service personnel, a fixed-term employment person
- Whose consent was not obtained
-Subjects with glaucoma, cholinergic urticaria, asthma, prostatic hypertrophy, a pregnant woman, the woman under breast-feeding
-Subjects with dermatoses in a test lesion

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Murota

Organization

Osaka university, School of medicine

Division name

Dermatology

Zip code


Address

2-2, Yamadaoka, Suita, Osaka

TEL

0668795111

Email

h-murota@derma.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name 0668795111

Organization

Osaka univeristy

Division name

Dermatology

Zip code


Address

2-2, yamadaoka, suita

TEL

0668795111

Homepage URL


Email

h-murota@derma.med.osaka-u.ac.jp


Sponsor or person

Institute

Dept. of dermatology, Osaka university

Institute

Department

Personal name



Funding Source

Organization

Dept. of dermatology, Osaka university

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 02 Month 19 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 11 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 02 Month 19 Day

Last modified on

2018 Year 12 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011805


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name